North American Star Consortium
$372,146UM1FY2022CANIH
University Health Network, Toronto ON
Investigators
Lillian L SiucontactPhilippe BedardKevin D CourtneySteven GrantSalma JabbourJeffrey LancetDevalingam Mahalingam
Linked publications & trials
Paper 39379134Paper 38264947Paper 38206848Paper 37852935Paper 37659346Paper 37419999Paper 37380217Paper 36911757Paper 36864346Paper 36826995Paper 36780008Paper 35994691Paper 35989139Paper 35789025Paper 35264434Paper 35130943Paper 34417144Paper 34392779Paper 33811119Paper 33485453Paper 32996059Paper 32816943Paper 32804778Paper 32738099Paper 32676589Paper 32097505Paper 31992589Paper 31165047Paper 30561713Paper 28864727Paper 28864726Paper 28864723Paper 26686201Paper 26473189Paper 25682963Paper 25355929Paper 25318436Paper 25290091Paper 25160636Paper 25015668Paper 24938562Paper 24788563Paper 24048068Paper 23645447
Abstract
North American Star Consortium (NASC) (CA-UM186644) is consisted of Princess Margaret Cancer Centre- University Health Network (PM-UHN) as its Lead Academic Organization (LAO) and 5 Affiliated Organizations (AOs): H. Lee Moffitt Cancer Center, Virginal Commonwealth University, University of Texas Southwestern, Northwestern University and The State University of New Jersey at Rutgers. In the first two years of its UM1 grant, NASC has exceeded its accrual target of 100 patients per year by 38 participants. This administrative supplement enables the additional funding per participant for this over- accrual.
View original record on NIH RePORTER →